Article
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Mar 2001
Tormene D, Simioni P, Sartori M T, Girolami A
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.